Skip to main content.

Daily Briefing: Medicaid Benefits, Hunting v. Sitting and Thalidomide

Daily Briefing: Medicaid Benefits, Hunting v. Sitting and Thalidomide

Picture of Nathanael Johnson

Medicaid: A study published in the New England Journal of Medicine found that Medicaid was associated with a 6.1 percent decline in deaths where states expanded the program, reports Pam Belluck for the New York Times.

Obesity: Researchers have found that people working at desks burn just as many calories as those hunting animals, which may suggest that the rise in obesity is more related to dietary changes than a shift to sedentary lifestyles, reports Susanne Rust for the Bay Citizen.

Thalidomide: An investigation by Nick McKenzie and Richard Baker at the Australian newspaper The Age, reveals that the maker of thalidomide had begun receiving evidence that the drug was damaging fetuses two years before it withdrew the drug from the market.

AIDS: HIV experts are laying out different strategies to pay for treatment of everyone infected with the virus, reports Richard Knox for NPR.

Preventive Medicine: Two papers delve into the role of prevention. In Health Affairs, David Lee and Frank Levy chart the causes and consequences of the sudden slowdown in medical imaging growth in 2006 and 2007. And in a New England Journal of Medicine perspective, Dave Chokshi and Thomas Farley argue that environmental approaches to prevention (like banning trans fats) are more cost-effective than clinical or non-clinical individualized approaches.

Want more from Reporting on Health? Join ussign up for our newsletterlike us on Facebook or follow us on Twitter.

Image by CharlesFred via Flickr

Leave A Comment


It's been a couple weeks of big headlines touting surprisingly high levels of vaccine efficacy from ongoing trials by Pfizer and Moderna. But huge logistical and ethical challenges remain in getting large swathes of the country vaccinated. Which groups should get their shots first? Join us for our next webinar on Nov. 24 (1-2 p.m. ET), when we’ll take an updated look at those hurdles, and discuss how you can translate this massive and urgent story for audiences in the weeks and months to come. Sign-up here!


Follow Us



CHJ Icon